HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- methylthio- N6- threonylcarbamoyladenosine

structure in first source

Also Known As:

ms(2)t(6)A; ms2t6A

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Infections 01/01/2022 - "t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity."
2.	COVID-19 01/01/2022 - "t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity." 01/01/2022 - "We found that two modified nucleosides, N6-threonylcarbamoyladenosine (t6A) and 2-methylthio-N6-threonylcarbamoyladenosine (ms2t6A), were elevated in serum and urine of COVID-19 patients. "

Related Drugs and Biologics

1.	2- methylthio- N6- threonylcarbamoyladenosine
2.	Biomarkers (Surrogate Marker)
3.	Nucleosides
4.	N(6)-(N-threonylcarbonyl)adenosine